Michael Maglin is the founder of CraniUS. CraniUS has raised $19M in total funding. Latest round: Series A. Backed by Private investors.
Michael Maglin is the CEO of CraniUS, a Baltimore-based neurotech company. He launched a $19.4 million Series A funding round in 2022 and is currently raising $20 million for a Series B. Maglin plans to submit an FDA application in early 2027, with commercialization targeted for late 2027 or early 2028.
Full founder directory · Investor directory · Company funding database · Fundraising library